Quadrant Capital Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-49
Closed 2110
2015
Q4
$0 Sell
49
-128
-72% ﹤0.01% 1780
2015
Q3
$0 Hold
177
﹤0.01% 1439
2015
Q2
$1K Buy
+177
New +$1K ﹤0.01% 1127